GlassScriptPhysician profile
Clinton C Pittman
NPI 1316938699
$33,815.76
in general payments reported to CMS, 2019-2025
7 companies · $35.68 in 2025
The $35.68 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $12K · 2021: $2,230 · 2022: $1,472 · 2023: $142 · 2024: $23.30 · 2025: $35.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $33,161.46 | 2019-2025 | Nimbl, Flexitouch Plus |
| Medtronic Vascular, INC. | $314.63 | 2019-2020 | |
| Cardiovascular Systems INC. | $142.10 | 2023 | Diamondback Peripheral |
| Angiodynamics, INC. | $107.95 | 2019-2021 | |
| Medline Industries LP | $48.47 | 2020 | |
| Bard Peripheral Vascular, INC. | $23.30 | 2024 | Venclose Maven Catheter |
| Merz North America, INC. | $17.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Pittman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.